MEDTRONIC PLC (2M6.DE) Fundamental Analysis & Valuation
FRA:2M6 • IE00BTN1Y115
Current stock price
70.92 EUR
-0.28 (-0.39%)
Last:
This 2M6.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. 2M6.DE Profitability Analysis
1.1 Basic Checks
- In the past year 2M6 was profitable.
- 2M6 had a positive operating cash flow in the past year.
- Each year in the past 5 years 2M6 has been profitable.
- 2M6 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With a decent Return On Assets value of 5.04%, 2M6 is doing good in the industry, outperforming 68.85% of the companies in the same industry.
- With a decent Return On Equity value of 9.42%, 2M6 is doing good in the industry, outperforming 65.57% of the companies in the same industry.
- 2M6 has a Return On Invested Capital of 6.57%. This is comparable to the rest of the industry: 2M6 outperforms 55.74% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for 2M6 is below the industry average of 10.31%.
- The 3 year average ROIC (6.35%) for 2M6 is below the current ROIC(6.57%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.04% | ||
| ROE | 9.42% | ||
| ROIC | 6.57% |
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
1.3 Margins
- With an excellent Profit Margin value of 13.00%, 2M6 belongs to the best of the industry, outperforming 80.33% of the companies in the same industry.
- In the last couple of years the Profit Margin of 2M6 has declined.
- With an excellent Operating Margin value of 18.98%, 2M6 belongs to the best of the industry, outperforming 80.33% of the companies in the same industry.
- 2M6's Operating Margin has been stable in the last couple of years.
- 2M6 has a Gross Margin of 65.16%. This is in the better half of the industry: 2M6 outperforms 70.49% of its industry peers.
- 2M6's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.98% | ||
| PM (TTM) | 13% | ||
| GM | 65.16% |
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
2. 2M6.DE Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 2M6 is creating some value.
- Compared to 1 year ago, 2M6 has less shares outstanding
- 2M6 has less shares outstanding than it did 5 years ago.
- 2M6 has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.83 indicates that 2M6 is not a great score, but indicates only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 2.83, 2M6 is in line with its industry, outperforming 52.46% of the companies in the same industry.
- 2M6 has a debt to FCF ratio of 5.19. This is a neutral value as 2M6 would need 5.19 years to pay back of all of its debts.
- 2M6 has a Debt to FCF ratio of 5.19. This is comparable to the rest of the industry: 2M6 outperforms 54.10% of its industry peers.
- A Debt/Equity ratio of 0.57 indicates that 2M6 is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.57, 2M6 is doing worse than 63.93% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 5.19 | ||
| Altman-Z | 2.83 |
ROIC/WACC1.02
WACC6.45%
2.3 Liquidity
- 2M6 has a Current Ratio of 2.54. This indicates that 2M6 is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 2.54, 2M6 is in the better half of the industry, outperforming 72.13% of the companies in the same industry.
- A Quick Ratio of 1.87 indicates that 2M6 should not have too much problems paying its short term obligations.
- The Quick ratio of 2M6 (1.87) is better than 77.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.54 | ||
| Quick Ratio | 1.87 |
3. 2M6.DE Growth Analysis
3.1 Past
- The Earnings Per Share has been growing slightly by 4.87% over the past year.
- The Earnings Per Share has been growing slightly by 3.68% on average over the past years.
- The Revenue has been growing slightly by 6.88% in the past year.
- The Revenue has been growing slightly by 3.01% on average over the past years.
EPS 1Y (TTM)4.87%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%-2.16%
Revenue 1Y (TTM)6.88%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%8.74%
3.2 Future
- The Earnings Per Share is expected to grow by 7.10% on average over the next years.
- The Revenue is expected to grow by 6.02% on average over the next years.
EPS Next Y2.83%
EPS Next 2Y5.59%
EPS Next 3Y6.24%
EPS Next 5Y7.1%
Revenue Next Year7.95%
Revenue Next 2Y7.24%
Revenue Next 3Y6.44%
Revenue Next 5Y6.02%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. 2M6.DE Valuation Analysis
4.1 Price/Earnings Ratio
- 2M6 is valuated correctly with a Price/Earnings ratio of 14.81.
- Based on the Price/Earnings ratio, 2M6 is valued cheaper than 93.44% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.42. 2M6 is valued slightly cheaper when compared to this.
- Based on the Price/Forward Earnings ratio of 13.52, the valuation of 2M6 can be described as correct.
- 2M6's Price/Forward Earnings ratio is rather cheap when compared to the industry. 2M6 is cheaper than 81.97% of the companies in the same industry.
- 2M6's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.24.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.81 | ||
| Fwd PE | 13.52 |
4.2 Price Multiples
- 65.57% of the companies in the same industry are more expensive than 2M6, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, 2M6 is valued a bit cheaper than 73.77% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.69 | ||
| EV/EBITDA | 12.16 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 2M6 does not grow enough to justify the current Price/Earnings ratio.
- 2M6 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.23
PEG (5Y)4.02
EPS Next 2Y5.59%
EPS Next 3Y6.24%
5. 2M6.DE Dividend Analysis
5.1 Amount
- 2M6 has a Yearly Dividend Yield of 3.32%.
- Compared to an average industry Dividend Yield of 1.26, 2M6 pays a better dividend. On top of this 2M6 pays more dividend than 91.80% of the companies listed in the same industry.
- 2M6's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.32% |
5.2 History
- The dividend of 2M6 has a limited annual growth rate of 5.10%.
Dividend Growth(5Y)5.1%
Div Incr Years8
Div Non Decr Years8
5.3 Sustainability
- 2M6 pays out 78.65% of its income as dividend. This is not a sustainable payout ratio.
- The dividend of 2M6 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP78.65%
EPS Next 2Y5.59%
EPS Next 3Y6.24%
2M6.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:2M6 (4/24/2026, 7:00:00 PM)
70.92
-0.28 (-0.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-17 2026-02-17/bmo
Earnings (Next)06-03 2026-06-03/amc
Inst Owners87.92%
Inst Owner ChangeN/A
Ins Owners0.28%
Ins Owner ChangeN/A
Market Cap91.05B
Revenue(TTM)35.48B
Net Income(TTM)4.61B
Analysts76.22
Price Target94.6 (33.39%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.32% |
Yearly Dividend2.35
Dividend Growth(5Y)5.1%
DP78.65%
Div Incr Years8
Div Non Decr Years8
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.66%
Min EPS beat(2)0.89%
Max EPS beat(2)2.43%
EPS beat(4)4
Avg EPS beat(4)1.6%
Min EPS beat(4)0.89%
Max EPS beat(4)2.43%
EPS beat(8)6
Avg EPS beat(8)1.11%
EPS beat(12)9
Avg EPS beat(12)1.9%
EPS beat(16)11
Avg EPS beat(16)1.33%
Revenue beat(2)2
Avg Revenue beat(2)0.17%
Min Revenue beat(2)0.08%
Max Revenue beat(2)0.26%
Revenue beat(4)4
Avg Revenue beat(4)0.35%
Min Revenue beat(4)0.08%
Max Revenue beat(4)0.91%
Revenue beat(8)7
Avg Revenue beat(8)0.23%
Revenue beat(12)10
Avg Revenue beat(12)0.48%
Revenue beat(16)12
Avg Revenue beat(16)0.07%
PT rev (1m)-1.36%
PT rev (3m)-0.57%
EPS NQ rev (1m)-3.45%
EPS NQ rev (3m)-5.15%
EPS NY rev (1m)-0.7%
EPS NY rev (3m)-0.78%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)0.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.26%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.81 | ||
| Fwd PE | 13.52 | ||
| P/S | 3 | ||
| P/FCF | 19.69 | ||
| P/OCF | 14.62 | ||
| P/B | 2.17 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.16 |
EPS(TTM)4.79
EY6.75%
EPS(NY)5.24
Fwd EY7.39%
FCF(TTM)3.6
FCFY5.08%
OCF(TTM)4.85
OCFY6.84%
SpS23.63
BVpS32.63
TBVpS-2.16
PEG (NY)5.23
PEG (5Y)4.02
Graham Number59.2989 (-16.39%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.04% | ||
| ROE | 9.42% | ||
| ROCE | 8.21% | ||
| ROIC | 6.57% | ||
| ROICexc | 7.32% | ||
| ROICexgc | 25.19% | ||
| OM | 18.98% | ||
| PM (TTM) | 13% | ||
| GM | 65.16% | ||
| FCFM | 15.24% |
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
ROICexc(3y)7.09%
ROICexc(5y)7.05%
ROICexgc(3y)29.85%
ROICexgc(5y)33.32%
ROCE(3y)7.94%
ROCE(5y)7.8%
ROICexgc growth 3Y-11.61%
ROICexgc growth 5Y-5.52%
ROICexc growth 3Y-2.49%
ROICexc growth 5Y3.26%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
F-Score7
Asset Turnover0.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 5.19 | ||
| Debt/EBITDA | 2.84 | ||
| Cap/Depr | 60.84% | ||
| Cap/Sales | 5.28% | ||
| Interest Coverage | 8.77 | ||
| Cash Conversion | 74.21% | ||
| Profit Quality | 117.26% | ||
| Current Ratio | 2.54 | ||
| Quick Ratio | 1.87 | ||
| Altman-Z | 2.83 |
F-Score7
WACC6.45%
ROIC/WACC1.02
Cap/Depr(3y)59.68%
Cap/Depr(5y)55.94%
Cap/Sales(3y)5.04%
Cap/Sales(5y)4.79%
Profit Quality(3y)124.85%
Profit Quality(5y)125.74%
High Growth Momentum
Growth
EPS 1Y (TTM)4.87%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%-2.16%
EPS Next Y2.83%
EPS Next 2Y5.59%
EPS Next 3Y6.24%
EPS Next 5Y7.1%
Revenue 1Y (TTM)6.88%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%8.74%
Revenue Next Year7.95%
Revenue Next 2Y7.24%
Revenue Next 3Y6.44%
Revenue Next 5Y6.02%
EBIT growth 1Y4.15%
EBIT growth 3Y-1.62%
EBIT growth 5Y3.4%
EBIT Next Year18.42%
EBIT Next 3Y11.24%
EBIT Next 5Y9.86%
FCF growth 1Y9.67%
FCF growth 3Y-4.64%
FCF growth 5Y-2.95%
OCF growth 1Y12.56%
OCF growth 3Y-1.39%
OCF growth 5Y-0.53%
MEDTRONIC PLC / 2M6.DE Fundamental Analysis FAQ
What is the ChartMill fundamental rating of MEDTRONIC PLC (2M6.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to 2M6.DE.
What is the valuation status for 2M6 stock?
ChartMill assigns a valuation rating of 5 / 10 to MEDTRONIC PLC (2M6.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for MEDTRONIC PLC?
MEDTRONIC PLC (2M6.DE) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for 2M6 stock?
The Price/Earnings (PE) ratio for MEDTRONIC PLC (2M6.DE) is 14.81 and the Price/Book (PB) ratio is 2.17.
Can you provide the financial health for 2M6 stock?
The financial health rating of MEDTRONIC PLC (2M6.DE) is 5 / 10.